Monitoring the activity of direct oral anticoagulants in a patient with severe nephrotic syndrome and pulmonary embolism. Lessons for the clinical nephrologist

J Nephrol. 2023 Jan;36(1):237-239. doi: 10.1007/s40620-022-01406-w. Epub 2022 Aug 5.
No abstract available

Keywords: Direct oral anticoagulants; Nephrotic syndrome; Pulmonary embolism.

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Humans
  • Nephrologists
  • Nephrotic Syndrome* / complications
  • Nephrotic Syndrome* / diagnosis
  • Nephrotic Syndrome* / drug therapy
  • Pulmonary Embolism* / drug therapy
  • Pulmonary Embolism* / etiology

Substances

  • Anticoagulants